top of page
COBI: Re:Balans® tracks fluid shifts during simulated hypovolemia
In a pilot with 11 healthy volunteers, participants underwent 40 minutes of lower-body negative pressure with Re:Balans® sensors placed on the lower leg, upper back, and midaxillary region. The lower half of the body was exposed to negative pressure, which causes a temporary shift of blood and fluid from the upper body to the lower body. The sensors showed high sensitivity to fluid volume shifts, detecting decreases in the upper body and corresponding increases in the lower body. These findings highlight the sensors’ ability to detect fluid volume changes and demonstrate its potential for monitoring dehydration and overhydration in relevant patient groups such as those with heart failure, kidney disease, stomas or sepsis. The study is published in Physiological Reports.​
REO: Re:Balans® detects mild dehydration induced by diuretics
Re:Balans® successfully monitored hydration changes in healthy volunteers undergoing mild dehydration induced by furosemide, a diuretic, followed by rehydration with Resorb Sport. A consistent decline in the Hydration Index was observed after furosemide administration, and the change showed a strong correlation with urine elimination. Hydration Index changes were consistent with blood test results both during dehydration and following intake of Resorb Sport. The study is published in Journal of Clinical Monitoring and Computing.​
Delage 2: Re:Balans® tracks fluid changes in dialysis patients
​Re:Balans® effectively tracked fluid changes in chronic kidney disease patients undergoing 2-6 hemodialysis sessions. A strong correlation was observed between fluid removal during dialysis and Mode's own Hydration Index. The Hydration Index also agreed with changes in body weight throughout the monitoring period. This study demonstrates the ability of Re:Balans® to monitor both rapid and gradual changes in hydration status. The study is published in BMC Nephrology.​
bottom of page